DARECCA JAMES (EVP, Chief Financial Officer) received a stock award from HAEMONETICS CORP
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/19/2026ACC: 0000313143-26-000046
Officer· EVP, Chief Financial Officer
Since Apr 2022
+26.81K
Net shares
Net buyer
$141.0K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
29.31K acquired · 2.50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−2.50K
Price / share
$56.29
Trade value
$141.01K
% of position
9.1%
5/15/2026
27.64K→25.13K
Common Stock
Direct
Shares
+29.31K
Price / share
—
Trade value
—
% of position
116.6%
5/15/2026
25.13K→54.44K
Total
Net shares
+26.81K
Net value
-$141.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/15/2026 | F · Tax Withholding | −2.50K | $56.29 | $141.01K | 9.1% | 27.64K | 25.13K |
| Common Stock Direct | 5/15/2026 | A · Award | +29.31K | — | — | 116.6% | 25.13K | 54.44K |
| Total | +26.81K | -$141.01K | ||||||
Derivative Transactions0
No derivative transactions reported